WOONSOCKET, R.I. , Nov. 11, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Wolfe 2024...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner, an industry veteran. The political landscape shift with Trump regaining the presidency...

Despite recent struggles, I remain bullish on CVS due to its potential for long-term growth and undervaluation, with a strong support level around $50. CVS faces challenges like high debt levels an...

CVS' third-quarter 2024 results reflect strong performance in the Health Services and Pharmacy & Consumer Wellness segments.

CVS Health Corporation (NYSE:CVS ) Q3 2024 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice Pr...

CVS Health (CVS) shares surged after the pharmacy chain and healthcare company posted better-than-expected results and new CEO David Joyner made leadership changes as he moves to shake up the strug...

CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.21 per share a year ago.

Third-quarter adjusted earnings per share was $1.09, confirming preliminary numbers from October. A Trump victory is also seen as beneficial as it's likely to benefit Medicare Advantage players.

CVS Health's David Joyner is expected to address how he will better manage rising patient costs in the Medicare business than his predecessor when he tackles his first earnings call as CEO on Wedne...

CVS Health (CVS) will report third-quarter earnings before the market opens Wednesday after the pharmacy and health-care provider had a rocky October that included a CEO change and layoffs, among o...

Besides Wall Street's top -and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during t...

CVS Health (CVS) closed at $56.25 in the latest trading session, marking a -1.94% move from the prior day.

Workers at seven CVS pharmacies in California are now on strike, seeking better pay and health care, as the stores remain open and staffed by managers and nonunion employees.

If you buy these stocks, you might be in for serious disappointment when they underperform.

CVS (CVS) has announced that it has replaced its CEO Karen Lynch with longtime executive David Joyner, sending shares sinking in Friday's trading session. Stephanie Davis, Barclays senior research ...